戻る
Nemaura Medical Inc (NMRD) 収入
NMRD 株価推移チャート
NMRD 収入
Nemaura Medical Inc
$0
0%
$0
終値： Apr 01, 16:00:00 GMT-4
$0
0%
$0
アフターマーケット：Apr 01, 20:00:00 GMT-4
最新の利益結果: Q3 '24
報告済み: 2024-02-12
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
NMRDの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Nemaura Medical Inc NMRDの前四半期の収益はどうでしたか？
Nemaura Medical Incの収益見積もりはいくらですか？
Nemaura Medical Incの収益品質スコアはどれくらいですか？
Nemaura Medical Incはいつ収益を報告しますか？
Nemaura Medical Incの予想収益はいくらですか？
Nemaura Medical Incは収益予想を上回りましたか？
主要データ
前終値
$0.0002
始値
$0.0002
当日レンジ
$0.0002 - $0.0002
52週レンジ
$0 - $0.0005
取引高
500
平均取引高
142
配当利回り
--
1株当たり利益(TTM)
-0.38
時価総額
$8.0K
NMRDとは何ですか？
Nemaura Medical, Inc. operates as a holding company. The company is headquartered in Manhattan, New York and currently employs 36 full-time employees. The company went IPO on 2014-11-04. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients and support obesity and weight-loss programs. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm. The Company’s applications of its technology include glucose monitoring, temperature monitoring, lactate monitoring, alcohol monitoring, and substance abuse monitoring. Its platform uses precision microsystems-based technology.